Rare genetic disorders

    We support innovative biotechs in Italy as they push promising research programs in rare genetic disorders towards preclinical and clinical development.

    Our unique collaboration with the Telethon Foundation aims to bring Italian scientific excellence to the world stage. Our mission is to foster a thriving biotech ecosystem in Italy.

    CloseFundAMT
    2018Sofinnova Telethon Fund€108 million
    • Close: 2018

      Fund: Sofinnova Telethon Fund

      AMT: €108 million

    “We come from the tech transfer world so we understand what it takes to build companies around the expertise at universities and institutions."

    “There has to be more willingness to invest in the early stage. If nobody had invested in mRNA technology 10 years ago, I don't think we would have had the Covid vaccine in less than one year.”

    Companies

    Fund iteration
    Status
    Deal lead

    Join our mailing list

    Keep up to date with our latest news.

    Required
    Thanks for submitting the form. You are now subscribed to Sofinnova Partners news alerts.An error happened. Please try again later.